Help | RSS Feed



Halozyme Therapeutics Inc. (NASD:HALO) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Halozyme Therapeutics Inc. (NASD:HALO) seasonal charts above shows that a Buy Date of December 16 and a Sell Date of March 19 has resulted in a geometric average return of 7.16% above the benchmark rate of the S&P 500 Total Return Index over the past 18 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success, but the return underperforms the relative buy-and-hold performance of the stock over the past 18 years by an average of 3.54% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company’s operations are based in the United States, with minimal long-lived assets located internationally.

To download HALO seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z